A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males
Clinical trial NCT03335254 · TERMINATED
Trial details
- NCT number
- NCT03335254
- Sponsor
- TesoRx Pharma, LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-06
- Primary completion
- 2018-05-03
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.